Novartis comments on $490m cell-culture vaccine contract

By Gareth Macdonald

- Last updated on GMT

Related tags: Influenza vaccine, Novartis

Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman Matt Stober about the new plant.

Late last week the US Department of Health and Human Services (HHS) awarded Novartis a $490m contract to continue work on its cell-culture influenza vaccine plant in Holly Springs, North Carolina, US. in-PharmaTechnologist spoke with Novartis spokesman Matt Stober about the new plant.

Related topics: Markets & Regulations

Related news

Follow us

Products

View more

Webinars